<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Freddy Buntoum

18+ years’ experience with expertise in Market Insights and Competitive Intelligence at major manufacturers in Medical Device and Crop Science, including 4+ years at Bioventus as a Sr. Manager, Market Insights.

Regenerative Medicine

IFATS 2019: An Interview With The GID Group

The GID Group – Prepping to revolutionize Regenerative Medicine with an innovative modular tissue proces...

Read now
Orthopedics

Q319 Soft Tissue Fixation Market Recap: Steady As She Goes

Steady as she goes...Soft Tissue Fixation Market on track to achieve SmartTRAK estimates for FY 2019 For...

Read now
Orthopedics

Q319 US Joint Fluid Market Recap: Essentially Flat

Single-injection holding the torch in a market essentially flat, impacted by ferocious pricing pressures...

Read now
Orthobiologics

TOBI 2019 Update: Issues & Trends in Orthobiologics

SmartTRAK's Senior Regenerative Medicine Analyst, Freddy Buntoum, attended TOBI 2019 this summer. Here's...

Read now
Orthopedics

Q219 US Joint Fluid Market Recap: Marginal Revenue Growth

Q219 saw marginal revenue growth amid single-injection momentum and competitive pricing pressure The num...

Read now
Regenerative Medicine

AAOS 2019: An Interview with OrthogenRx CEO Michael Daley

OrthogenRx CEO & Founder Michael Daley talks about the Company’s new 3-injection HA product, TriVisc...

Read now
Orthopedics

Q119 Joint Fluid Market: Revenues Down, Pricing Pressures and FDA Scrutiny

Revenues down again, competitive pricing pressures remain, market is under FDA scrutiny After a sluggish...

Read now
Orthopedics

Q418/FY18 Joint Fluid Market Recap

Revenues down again, owing to intense competitive pricing pressures Pricing pressure continued to negati...

Read now
1 2 3 4